Ascletis Pharma files HKEX next-day disclosure return announcing share repurchase for cancellation

• Ascletis Pharma repurchased 200,000 shares on HKEX for cancellation, HKD 8.83–9.18 each; aggregate consideration HKD 1.79 million.
• Issued shares held as treasury shares stayed at 5,784,210; total issued shares unchanged at 1,057,769,055 as of July 28.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260728-12258799), on July 28, 2026, and is solely responsible for the information contained therein.